Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01554501 · ClinicalTrials.gov registry record
The Role of Stress in Self-Control, Coping, and Emotion Regulation
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 855
- Enrollment target
NCT01554501: Completed study, sponsored by Yale University.
NCT01554501 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 855 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01554501 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 855 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of stress on mental and physical health and behavior.
Primary Outcome
Study explores differences in measures of stress as they relate to self-control, coping, emotion regulation and lifestyle and health outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 855 participants |
| Start Date | 2007-11 |
| Est. Completion | 2015-12 |
What the finished NCT01554501 record still lists
NCT01554501 is an observational study that tracks outcomes without assigning an intervention. The registered 855 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01554501 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01554501 about?
NCT01554501 is a clinical study titled "The Role of Stress in Self-Control, Coping, and Emotion Regulation". The purpose of this study is to examine the effects of stress on mental and physical health and behavior.
What is the current status of trial NCT01554501?
This trial is currently completed. The enrollment target is 855 participants. The study started on 2007-11. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01554501?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05108896 · 855 participants · NA
Aspiration in Acute Respiratory Failure Survivors 2
- NCT06231485 · 856 participants · NA
Socialization To Enrich Participation & Support Sexuality for Young People With I/DD
- NCT07005102 · 854 participants · Phase 2
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- NCT07290491 · 854 participants · Phase 3
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia